Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD

被引：0
|
作者：
Simpson, E. L. [1 ]
Hong, H. C. [2 ,3 ]
Marcoux, D. [4 ,5 ]
Chen, Z. [6 ]
Bego-Le Bagousse, G. [7 ]
Wang, J. [6 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ British Columbia, Surrey, BC, Canada
[3] Prob Med Res, Waterloo, ON, Canada
[4] Univ Montreal, Montreal, PQ, Canada
[5] St Justine Univ, Med Ctr, Montreal, PQ, Canada
[6] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[7] Sanofi, Chilly Mazarin, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
485
引用
收藏
页码：E121 / E122
页数：2
相关论文
共 50 条
  • [1] Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, Amy S.
    Simpson, Eric L.
    Beck, Lisa A.
    Hong, H. Chih-Ho
    Marcoux, Danielle
    Chen, Zhen
    Shumel, Brad
    Bansal, Ashish
    Rossi, Ana B.
    Chao, Jingdong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB139 - AB139
  • [2] Dupilumab provides sustained improvement of sleep disturbance in children ≥6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A. S.
    Wollenberg, A.
    Simpson, E. L.
    Beck, L. A.
    Chih-ho, Hong H.
    Marcoux, D.
    Bastian, M.
    Chen, Z.
    Levit, N. A.
    Bansal, A.
    Rossi, A. B.
    Chao, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 97 - 98
  • [3] Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A.
    Wollenberg, A.
    Simpson, E.
    Beck, L.
    Hong, C-H
    Marcoux, D.
    Chen, Z.
    Levit, N.
    Bansal, A.
    Rossi, A.
    Chao, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 57 - 58
  • [4] DUPILUMAB PROVIDES EARLY AND SUSTAINED IMPROVEMENT IN SLEEP IN ADOLESCENTS AND ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Beck, Lisa A.
    Simpson, Eric L.
    de Bruin-Weller, Marjolein
    Wollenberg, Andreas
    Kataoka, Yoko
    Barbarot, Sebastien
    Bansal, Ashish
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Prescilla, Randy
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 54 - 54
  • [5] Dupilumab offers early and sustained improvement in sleep in adolescents with moderate-to-severe atopic dermatitis
    Beck, L. A.
    Simpson, E. L.
    Hong, H. C. H.
    Bansal, A.
    Chen, Z.
    Mina-Osorio, P.
    Prescilla, R.
    Gadkari, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E95 - E95
  • [6] Dupilumab Offers Early and Sustained Improvement in Sleep in Adolescents With Moderate-to-Severe Atopic Dermatitis
    Simpson, Eric
    Eckert, Laurent
    Hong, Chih-Ho
    Bansal, Ashish
    Chen, Zhen
    Prescilla, Randy
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 23 - 24
  • [7] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [8] DUPILUMAB DECREASES TOTAL AND ALLERGEN-SPECIFIC IGE IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS (AD)
    Simpson, E.
    Cork, M.
    Arkwright, P.
    Deleuran, M.
    Chen, Z.
    Rodriguez Marco, A.
    Cyr, S.
    Harel, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S54 - S55
  • [9] Dupilumab provides clinically meaningful responses in adults with moderate-to-severe atopic dermatitis (AD): Results from LIBERTY AD CHRONOS study
    Silverberg, Jonathan I.
    Simpson, Eric L.
    de Bruin-Weller, Marjolein
    Foley, Peter
    Kataoka, Yoko
    Chen, Zhen
    Shumel, Brad
    Rossi, Ana B.
    Sierka, Debra
    Chao, Jingdong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB152 - AB152
  • [10] Dupilumab provides clinically meaningful responses in adults with moderate-to-severe atopic dermatitis (AD): Results from LIBERTY AD CHRONOS study
    Silverberg, J., I
    Simpson, E. L.
    Bieber, T.
    de Bruin-Weller, M.
    Foley, P.
    Kataoka, Y.
    Bastian, M.
    Chen, Z.
    Levit, N. A.
    Rossi, A. B.
    Sierka, D.
    Chao, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 61 - 61
12345